GlassScriptPhysician profile
Sujatha Vivek
NPI 1013927003
$1,588.41
in general payments reported to CMS, 2019-2025
22 companies · $56.19 in 2025
The $56.19 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $396 · 2021: $500 · 2022: $86.79 · 2023: $50.27 · 2024: $131 · 2025: $56.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $280.43 | 2020-2022 | |
| Cardiovascular Systems INC. | $169.47 | 2019-2020 | |
| Angiodynamics, INC. | $165.70 | 2020 | |
| Coopersurgical, INC. | $147.61 | 2019-2021 | |
| Boston Scientific Corporation | $131.35 | 2019-2024 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $123.41 | 2021 | |
| Exeltis, USA INC. | $81.53 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $79.28 | 2020 | |
| Caldera Medical, INC | $74.90 | 2021 | |
| Astellas Pharma US INC | $46.86 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $37.01 | 2019-2021 | |
| Baxter Healthcare | $36.93 | 2024 | Perclot |
| Pfizer INC. | $36.20 | 2025 | |
| Medtronic, INC. | $34.83 | 2024 | Interstim |
| Ethicon US, LLC | $32.30 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $24.40 | 2019 | |
| Shield Therapeutics INC | $16.32 | 2022 | |
| Ekos Corporation | $15.19 | 2019 | |
| Medicem INC. | $13.82 | 2021 | |
| Lupin INC. | $13.81 | 2020 | |
| Therapeuticsmd, INC. | $13.67 | 2020 | |
| Allergan, INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujatha Vivek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.